(2R,3R,4S,5R)-2-(6-(((5-Bromothiophen-2-yl)methyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

Catalog No. :
ACCRKK638
CAS No. :
1706525-09-8
Molecular Formula :
C15H16BrN5O4S
Molecular Weight :
442.30

IUPAC Name:(2R,3R,4S,5R)-2-(6-(((5-bromothiophen-2-yl)methyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

(2R,3R,4S,5R)-2-(6-(((5-Bromothiophen-2-yl)methyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$217.00Login to see priceInquiryInquiry
100mg98%$651.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R,4S,5R)-2-(6-(((5-Bromothiophen-2-yl)methyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
IUPAC Name(2R,3R,4S,5R)-2-(6-(((5-bromothiophen-2-yl)methyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
Molecular FormulaC15H16BrN5O4S
Molecular Weight442.30
SMILESO[C@H]1[C@H](N2C=NC3=C(NCC4=CC=C(Br)S4)N=CN=C23)O[C@H](CO)[C@H]1O
InChI KeyNMCXSKQZGXWJCZ-PMXXHBEXSA-N
SynonymN6-[(5-Bromothien-2-yl)methyl]adenosine;Adenosine, N-[(5-bromo-2-thienyl)methyl]-
CAS No.1706525-09-8

Synthetic Route by SureRoute

1. ACCRKK638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZJSE629 route compound structure diagram
    ACZJSE6291001414-56-7 In Stock
  2. Plus
  3. ACEZLX896 route compound structure diagram
    ACEZLX8965399-87-1 In Stock
  4. Then
  5. ACCRKK638 route product structure diagram
    ACCRKK6381706525-09-8
Inquiry

2. ACCRKK638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZJSE629 route compound structure diagram
    ACZJSE6291001414-56-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCRKK638 route product structure diagram
    ACCRKK6381706525-09-8
Inquiry

Comments (0)